MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis

被引:75
作者
Schneider, C
Gold, R
Dalakas, MC
Schmied, M
Lassmann, H
Toyka, KV
Hartung, HP
机构
[1] UNIV WURZBURG, DEPT NEUROL, CLIN RES UNIT MULTIPLE SCLEROSIS, D-8700 WURZBURG, GERMANY
[2] NINCDS, NIH, BETHESDA, MD USA
[3] AUSTRIAN ACAD SCI, EXPT NEUROPATHOL RES UNIT, A-1010 VIENNA, AUSTRIA
关键词
autoimmune disorders; Fas antigen; human inflammatory myopathies; MHC class I cytotoxicity; T cell apoptosis;
D O I
10.1097/00005072-199612000-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Apoptosis plays a crucial role in natural recovery from T cell-mediated autoimmune disorders of the nervous system. Whether apoptosis also occurs in human inflammatory myopathies is unclear. In this study we examined muscle biopsy specimens from untreated patients with polymyositis (n = 12), dermatomyositis (n = 12), and inclusion body myositis (n = 12) for the presence of apoptosis using morphological criteria and DNA fragmentation by in situ tailing. In all these disorders, only rare T cells exhibited signs of apoptosis by nuclear morphology and in situ labeling techniques. Although Fas-expression was upregulated in a few inflammatory cells, increased apoptosis of the surrounding T cells was not observed. Further, nuclei of degenerating muscle fibers did not show morphological signs of apoptosis and were not labeled by the tailing reaction. We conclude that in the inflammatory myopathies, T cell inflammation is not cleared by apoptosis and affected muscle fibers do not die by apoptosis. The observations are consistent with the non-self-limited nature of these disorders and suggest that, in contrast to the nervous system, the local microenvironment in muscle does not deliver pro-apoptotic stimuli.
引用
收藏
页码:1205 / 1209
页数:5
相关论文
共 28 条
[1]   MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .4. CELL-MEDIATED CYTO-TOXICITY AND MUSCLE-FIBER NECROSIS [J].
ARAHATA, K ;
ENGEL, AG .
ANNALS OF NEUROLOGY, 1988, 23 (02) :168-173
[2]  
BARACLATES V, 1996, IN PRESS REG IMMUNOL
[3]   T-CELL RECEPTOR REPERTOIRE IN POLYMYOSITIS - CLONAL EXPANSION OF AUTOAGGRESSIVE CD8(+) T-CELLS [J].
BENDER, A ;
ERNST, N ;
IGLESIAS, A ;
DORNMAIR, K ;
WEKERLE, H ;
HOHLFELD, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1863-1868
[4]   DETERMINATION OF THE LENGTH OF THE HISTOLOGICAL STAGES OF APOPTOSIS IN NORMAL LIVER AND IN ALTERED HEPATIC FOCI OF RATS [J].
BURSCH, W ;
PAFFE, S ;
PUTZ, B ;
BARTHEL, G ;
SCHULTEHERMANN, R .
CARCINOGENESIS, 1990, 11 (05) :847-853
[5]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[6]   T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CRITCHFIELD, JM ;
RACKE, MK ;
ZUNIGAPFLUCKER, JC ;
CANNELLA, B ;
RAINE, CS ;
GOVERMAN, J ;
LENARDO, MJ .
SCIENCE, 1994, 263 (5150) :1139-1143
[7]   POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].
DALAKAS, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498
[8]  
Engel AG, 1994, MYOLOGY, P822
[9]   PATHOGENESIS OF MULTIPLE-SCLEROSIS [J].
FFRENCHCONSTANT, C .
LANCET, 1994, 343 (8892) :271-275
[10]  
GALLARDO E, 1995, NEUROLOGY, V45, pA236